Infertility
Conditions
Sponsors
Dextra fertility clinic
Annika Tulenheimo-Silfvast
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Ferritin level under 30 ug/l, age 18-42 year and on full concent ,AMH over 1 ug/L , PLANNED FOR IVF/ICSI TREATMENT Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 62 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Endometriosis, IBD , colitis ulcerosa , renal insuffiency, cardiac insuffiency.clinical evidence of iron overload or disturbances in utilisation of iron
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Evaluate the effects of intravenous iron supplementation on the embryo quality;Secondary Objective: evaluate blastulation rate , ongoing pregnancy rate , number of mature oocytes , fertilization rate, implantation rate;Primary end point(s): Number of ggood quality blastocysts ;Timepoint(s) of evaluation of this end point: 5-7 days after oocyte pick up | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): blastulation rate , ongoing pregnancy rate , number of mature oocytes , fertilization rate, implantation rate;Timepoint(s) of evaluation of this end point: 1-7 days after oocyte pick up , the day of pregnancy test and ongoing pregnancy | — |
Countries
Finland
Contacts
Public ContactAnnika Tulenheimo-Silfvast
Dextra fertility clinic
Outcome results
None listed